Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of fostemsavir in heavily treatment-experienced adults with multidrug-resistant HIV-1
2014-002111-41Phase 3Active
- Sponsor
- Bristol Myers Squibb
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Human immunodeficiency virus infection type 1 comparing Fostemsavir arm with Placebo arm (2 arms). Primary endpoint: Mean change in log10 HIV-1 RNA. Started Feb 2015; status: active.
02
Drugs
fostemsavir
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2014-002111-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002111-41.